Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in J Neurochem

Retrieve available abstracts of 105 articles:
HTML format

Single Articles

    September 2021
  1. JAKARIA M, Belaidi AA, Bush AI, Ayton S, et al
    Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    J Neurochem. 2021 Sep 23. doi: 10.1111/jnc.15519.
    PubMed     Abstract available

    July 2021
  2. MICHNO W, Blennow K, Zetterberg H, Brinkmalm G, et al
    Refining the amyloid beta peptide and oligomer fingerprint ambiguities in Alzheimer's disease: mass spectrometric molecular characterization in brain, CSF, blood and plasma.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15466.
    PubMed     Abstract available

  3. KORECKA M, Shaw LM
    Mass spectrometry-based methods for robust measurement of Alzheimer's Disease biomarkers in biological fluids.
    J Neurochem. 2021 Jul 10. doi: 10.1111/jnc.15465.
    PubMed     Abstract available

  4. Retraction: Clinical trials in Alzheimer's disease': immunotherapy approaches.
    J Neurochem. 2021 Jul 6. doi: 10.1111/jnc.15435.
    PubMed     Abstract available

    June 2021
  5. CORTES-GOMEZ MA, Llorens-Alvarez E, Alom J, Del Ser T, et al
    Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression.
    J Neurochem. 2021;157:2091-2105.
    PubMed     Abstract available

    May 2021
  6. LI KY, Xiang XJ, Song L, Chen J, et al
    Mitochondrial TXN2 attenuates amyloidogenesis via selective inhibition of BACE1 expression.
    J Neurochem. 2021;157:1351-1365.
    PubMed     Abstract available

    April 2021
  7. LEE-LIU D, Gonzalez-Billault C
    Neuron-intrinsic origin of hyperexcitability during early pathogenesis of Alzheimer's disease: An Editorial Highlight for "Hippocampal hyperactivity in a rat model of Alzheimer's disease" on https://doi.org/10.1111/jnc.15323.
    J Neurochem. 2021 Apr 28. doi: 10.1111/jnc.15248.
    PubMed     Abstract available

  8. SUN L, Bhawal R, Xu H, Chen H, et al
    The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease.
    J Neurochem. 2021 Apr 27. doi: 10.1111/jnc.15377.
    PubMed     Abstract available

  9. VAN DER VELPEN V, Rosenberg N, Maillard V, Teav T, et al
    Sex-specific alterations in NAD+ metabolism in triple transgenic Alzheimer's disease mouse brain assessed by quantitative targeted liquid chromatography - mass spectrometry.
    J Neurochem. 2021 Apr 8. doi: 10.1111/jnc.15362.
    PubMed     Abstract available

    March 2021
  10. BUTLER CA, Thornton P, Brown GC
    CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
    J Neurochem. 2021 Mar 15. doi: 10.1111/jnc.15349.
    PubMed     Abstract available

  11. CHEN H, Cross AC, Thakkar A, Xu H, et al
    Selective linkage of mitochondrial enzymes to intracellular calcium stores differs between human-induced pluripotent stem cells, neural stem cells, and neurons.
    J Neurochem. 2021;156:867-879.
    PubMed     Abstract available

    February 2021
  12. SOSULINA L, Mittag M, Geis HR, Hoffmann K, et al
    Hippocampal hyperactivity in a rat model of Alzheimer's disease.
    J Neurochem. 2021 Feb 14. doi: 10.1111/jnc.15323.
    PubMed     Abstract available

  13. ARBER C, Alatza A, Leckey CA, Paterson RW, et al
    Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
    J Neurochem. 2021 Feb 4. doi: 10.1111/jnc.15315.
    PubMed     Abstract available

    January 2021
  14. HUANG SJ, Ma YH, Bi YL, Shen XN, et al
    Metabolically healthy obesity and lipids may be protective factors for pathological changes of Alzheimer's disease in cognitively normal adults.
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15306.
    PubMed     Abstract available

  15. GRUNDER G, Cumming P
    Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15269.
    PubMed     Abstract available

  16. HARK TJ, Savas JN
    Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology.
    J Neurochem. 2021 Jan 12. doi: 10.1111/jnc.15298.
    PubMed     Abstract available

    December 2020
  17. HIGHET B, Anekal PV, Ryan B, Murray H, et al
    fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer's disease using an automated quantitative analysis workflow.
    J Neurochem. 2020 Dec 25. doi: 10.1111/jnc.15283.
    PubMed     Abstract available

  18. STOLERO N, Frenkel D
    The Dialog between Neurons and Microglia in Alzheimer's Disease: The Neurotransmitters View.
    J Neurochem. 2020 Dec 12. doi: 10.1111/jnc.15262.
    PubMed     Abstract available

  19. YUEDE CM, Wallace CE, Davis TA, Gardiner WD, et al
    Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Dec 5. doi: 10.1111/jnc.15260.
    PubMed     Abstract available

    Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease: An Editorial Highlight for "Riluzole attenuates glutamatergic tone and cognitive decline in AbetaPP/PS1 mice
    J Neurochem. 2020 Dec 4. doi: 10.1111/jnc.15238.
    PubMed     Abstract available

  21. LI W, Wu M, Zhang Y, Wei X, et al
    Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK-3beta in 3xTg-AD mice.
    J Neurochem. 2020;155:697-713.
    PubMed     Abstract available

    November 2020
  22. LI L, Miao M, Chen J, Liu Z, et al
    Role of Tet2 in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Nov 9. doi: 10.1111/jnc.15234.
    PubMed     Abstract available

  23. VINKLAROVA L, Schmidt M, Benek O, Kuca K, et al
    Friend or enemy? Review of 17beta-HSD10 and its role in human health or disease.
    J Neurochem. 2020;155:231-249.
    PubMed     Abstract available

    October 2020
  24. LIMEGROVER CS, LeVine H 3rd, Izzo NJ, Yurko R, et al
    Alzheimer's Protection Effect of A673T Mutation May Be Driven by Lower Abeta Oligomer Binding Affinity.
    J Neurochem. 2020 Oct 6. doi: 10.1111/jnc.15212.
    PubMed     Abstract available

    September 2020
  25. GAUNITZ S, Tjernberg LO, Schedin-Weiss S
    The N-glycan profile in cortex and hippocampus is altered in Alzheimer s disease.
    J Neurochem. 2020 Sep 28. doi: 10.1111/jnc.15202.
    PubMed     Abstract available

  26. PENA-BAUTISTA C, Alvarez L, Baquero M, Ferrer I, et al
    Plasma isoprostanoids assessment as Alzheimer Disease progression biomarkers.
    J Neurochem. 2020 Sep 12. doi: 10.1111/jnc.15183.
    PubMed     Abstract available

  27. PEREIRA JD, Fraga VG, Santos ALM, das Gracas Carvalho M, et al
    Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies.
    J Neurochem. 2020 Sep 9. doi: 10.1111/jnc.15166.
    PubMed     Abstract available

  28. BROSSERON F, Kleemann K, Kolbe CC, Santarelli F, et al
    Interrelations of Alzheimer s disease candidate biomarkers neurogranin, fatty acid binding protein 3 and ferritin to neurodegeneration and neuroinflammation.
    J Neurochem. 2020 Sep 7. doi: 10.1111/jnc.15175.
    PubMed     Abstract available

  29. PEDRINI S, Chatterjee P, Hone E, Martins RN, et al
    High Density Lipoprotein-related cholesterol metabolism in Alzheimer's Disease.
    J Neurochem. 2020 Sep 5. doi: 10.1111/jnc.15170.
    PubMed     Abstract available

    August 2020
  30. WANG L, Liu S, Xu J, Watanabe N, et al
    Emodin inhibits Abeta42 aggregation and improves cognitive deficits in Alzheimer's disease transgenic mice.
    J Neurochem. 2020 Aug 16. doi: 10.1111/jnc.15156.
    PubMed     Abstract available

  31. MOSSER S, Gerber H, Fraering PC
    Identification of truncated C-terminal fragments of the Alzheimer's disease amyloid protein precursor derived from sequential proteolytic pathways.
    J Neurochem. 2020 Aug 5. doi: 10.1111/jnc.15143.
    PubMed     Abstract available

    July 2020
  32. SIMOES-PIRES EN, Ferreira ST, Linden R
    Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular and Alzheimer's diseases.
    J Neurochem. 2020 Jul 19. doi: 10.1111/jnc.15129.
    PubMed     Abstract available

  33. MARTINS TS, Trindade D, Vaz M, Campelo I, et al
    Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
    J Neurochem. 2020 Jul 3. doi: 10.1111/jnc.15112.
    PubMed     Abstract available

  34. SATHE G, Albert M, Darrow J, Saito A, et al
    Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15116.
    PubMed     Abstract available

  35. GUNN AP, Wong BX, McLean C, Fowler C, et al
    Increased glutaminyl cyclase activity in brain of Alzheimer's disease individuals.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15114.
    PubMed     Abstract available

    May 2020
  36. DE FREITAS GB, Lourenco MV, De Felice FG
    Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.
    J Neurochem. 2020 May 12. doi: 10.1111/jnc.15039.
    PubMed     Abstract available

    The lipid component of Alzheimer's disease research: An Editorial Highlight for "Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice" on https://do
    J Neurochem. 2020 May 6. doi: 10.1111/jnc.15025.
    PubMed     Abstract available

    April 2020
  38. FONTANA IC, Zimmer AR, Rocha AS, Gosmann G, et al
    Amyloid-beta oligomers in cellular models of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15030.
    PubMed     Abstract available

  39. LI Z, Zhu H, Guo Y, Du X, et al
    Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15031.
    PubMed     Abstract available

  40. BULLAIN S, Doody R
    What works and what doesn't work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials.
    J Neurochem. 2020 Apr 11. doi: 10.1111/jnc.15023.
    PubMed     Abstract available

    March 2020
  41. RAJAEI S, Karima S, Sepasi Tehrani H, Shateri S, et al
    Conformational Change and GTPase Activity of Human Tubulin: A Comparative Study on Alzheimer's Disease and Healthy Brain.
    J Neurochem. 2020 Mar 20. doi: 10.1111/jnc.15009.
    PubMed     Abstract available

  42. LI S, Selkoe DJ
    A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Ab oligomers from Alzheimer brain.
    J Neurochem. 2020 Mar 17. doi: 10.1111/jnc.15007.
    PubMed     Abstract available

  43. LI B, Liu J, Gu G, Han X, et al
    Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level and synaptic deficits in Alzheimer's disease.
    J Neurochem. 2020 Mar 7. doi: 10.1111/jnc.15001.
    PubMed     Abstract available

  44. KAYA I, Jennische E, Lange S, Baykal AT, et al
    Brain Region Specific Amyloid Plaque Associated Myelin Lipid Loss, APOE Deposition and Disruption of the Myelin Sheath in Familial Alzheimer's Disease Mice.
    J Neurochem. 2020 Mar 5. doi: 10.1111/jnc.14999.
    PubMed     Abstract available

    February 2020
  45. HIERRO-BUJALANCE C, Del Marco A, Ramos-Rodriguez JJ, Infante-Garcia C, et al
    Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
    J Neurochem. 2020 Feb 18. doi: 10.1111/jnc.14987.
    PubMed     Abstract available

    January 2020
  46. HOU TY, Zhou Y, Zhu LS, Wang X, et al
    Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    J Neurochem. 2020 Jan 17:e14961. doi: 10.1111/jnc.14961.
    PubMed     Abstract available

    November 2019
  47. IMAMURA O, Arai M, Dateki M, Oishi K, et al
    Donepezil-induced oligodendrocyte differentiation is mediated through estrogen receptors.
    J Neurochem. 2019 Nov 28. doi: 10.1111/jnc.14927.
    PubMed     Abstract available

    October 2019
  48. MICHNO W, Wehrli P, Meier S, Sehlin D, et al
    Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Abeta Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
    J Neurochem. 2019 Oct 12. doi: 10.1111/jnc.14888.
    PubMed     Abstract available

    September 2019
  49. WIJASA TS, Sylvester M, Brocke-Ahmadinejad N, Schwartz S, et al
    Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.
    J Neurochem. 2019 Sep 14. doi: 10.1111/jnc.14870.
    PubMed     Abstract available

    August 2019
  50. ZHU B, Li Z, Qian PY, Herrup K, et al
    Marine bacterial extracts as a new rich source of drugs against Alzheimer's disease.
    J Neurochem. 2019 Aug 5. doi: 10.1111/jnc.14847.
    PubMed     Abstract available

  51. SORGDRAGER FJH, Vermeiren Y, Van Faassen HJR, Van Der Ley CP, et al
    Age- and Disease-Specific Changes of the Kynurenine Pathway in Parkinson's and Alzheimer's Disease.
    J Neurochem. 2019 Aug 3. doi: 10.1111/jnc.14843.
    PubMed     Abstract available

    June 2019
  52. NICHOLS MR, St-Pierre MK, Wendeln AC, Makoni NJ, et al
    Inflammatory mechanisms in neurodegeneration.
    J Neurochem. 2019;149:562-581.
    PubMed     Abstract available

    May 2019
  53. GARCIA-AYLLON MS, Monge-Argiles JA, Monge-Garcia V, Navarrete F, et al
    Measurement of CSF proportional, variant-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
    J Neurochem. 2019 May 11. doi: 10.1111/jnc.14719.
    PubMed     Abstract available

    April 2019
  54. MURAMATSU I, Uwada J, Yoshiki H, Sada K, et al
    Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
    J Neurochem. 2019 Apr 10. doi: 10.1111/jnc.14701.
    PubMed     Abstract available

    February 2019
  55. JHA NK, Jha SK, Kar R, Nand P, et al
    Nuclear Factor-Kappa beta as a therapeutic target for Alzheimer's disease.
    J Neurochem. 2019 Feb 25. doi: 10.1111/jnc.14687.
    PubMed     Abstract available

    January 2019
  56. HASCUP ER, Broderick SO, Russell MK, Fang Y, et al
    Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AbetaPP/PS1 mice.
    J Neurochem. 2019;148:219-237.
    PubMed     Abstract available

    December 2018
  57. CLINE EN, Das A, Bicca MA, Mohammad SN, et al
    A Novel Crosslinking Protocol Stabilizes Amyloid beta Oligomers Capable of Inducing Alzheimer's-Associated Pathologies.
    J Neurochem. 2018 Dec 18. doi: 10.1111/jnc.14647.
    PubMed     Abstract available

    November 2018
  58. CILENTO EM, Jin L, Stewart T, Shi M, et al
    Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer's and Parkinson's Diseases.
    J Neurochem. 2018 Nov 26. doi: 10.1111/jnc.14635.
    PubMed     Abstract available

    October 2018
  59. CHANEY A, Williams SR, Boutin H
    In vivo Molecular Imaging of Neuroinflammation in Alzheimer's disease.
    J Neurochem. 2018 Oct 19. doi: 10.1111/jnc.14615.
    PubMed     Abstract available

  60. CISTERNAS P, Zolezzi JM, Martinez M, Torres VI, et al
    Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease.
    J Neurochem. 2018 Oct 9. doi: 10.1111/jnc.14608.
    PubMed     Abstract available

    September 2018
  61. BUTTERFIELD DA, Boyd-Kimball D
    Redox Proteomics and Amyloid beta-Peptide: Insights into Alzheimer Disease.
    J Neurochem. 2018 Sep 14. doi: 10.1111/jnc.14589.
    PubMed     Abstract available

    Calcineurin: directing the damage in Alzheimer disease: An Editorial for 'Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain' on doi: 10.1111/jnc.14469.
    J Neurochem. 2018 Sep 7. doi: 10.1111/jnc.14475.
    PubMed     Abstract available

    July 2018
  63. GRANGER MW, Liu H, Fowler CF, Blanchard AP, et al
    Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's Disease mouse models.
    J Neurochem. 2018 Jul 24. doi: 10.1111/jnc.14560.
    PubMed     Abstract available

    May 2018
  64. HOPP SC, Bihlmeyer NA, Corradi JP, Vanderburg C, et al
    Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.
    J Neurochem. 2018 May 28. doi: 10.1111/jnc.14469.
    PubMed     Abstract available

    April 2018
  65. CALVO-FLORES GUZMAN B, Vinnakota C, Govindpani K, Waldvogel H, et al
    The GABAergic System as a Therapeutic Target for Alzheimer's Disease.
    J Neurochem. 2018 Apr 12. doi: 10.1111/jnc.14345.
    PubMed     Abstract available

    March 2018
  66. MARWARHA G, Schommer J, Lund J, Schommer T, et al
    Palmitate-induced C/EBP homologous protein activation leads to NF-kappaB-mediated increase in BACE1 activity and amyloid beta genesis.
    J Neurochem. 2018;144:761-779.
    PubMed     Abstract available

  67. BAZZIGALUPPI P, Beckett TL, Koletar MM, Lai AY, et al
    Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
    J Neurochem. 2018;144:669-679.
    PubMed     Abstract available

    Prevention of cognitive impairment: scientific guidance and windows of opportunity.
    J Neurochem. 2018;144:609-616.
    PubMed     Abstract available

    February 2018
  69. KWAKOWSKY A, Calvo-Flores Guzman B, Pandya M, Turner C, et al
    GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
    J Neurochem. 2018 Feb 27. doi: 10.1111/jnc.14325.
    PubMed     Abstract available

  70. SAADIPOUR K, Manucat-Tan NB, Lim Y, Keating DJ, et al
    p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis.
    J Neurochem. 2018;144:302-317.
    PubMed     Abstract available

    January 2018
  71. GARNER B, Ooi L
    Wnt is here! Could Wnt signalling be promoted to protect against Alzheimer disease?: An Editorial for 'Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20- APP transgenic and wild-type mice' on do
    J Neurochem. 2018 Jan 26. doi: 10.1111/jnc.14276.
    PubMed     Abstract available

  72. PAN Y, Choy KHC, Marriott PJ, Chai SY, et al
    Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
    J Neurochem. 2018;144:81-92.
    PubMed     Abstract available

    December 2017
  73. NUCERA A, Hachinski V
    Cerebrovascular and alzheimer disease: fellow travellers or partners in crime?
    J Neurochem. 2017 Dec 21. doi: 10.1111/jnc.14283.
    PubMed     Abstract available

  74. KACZMARCZYK R, Tejera D, Simon BJ, Heneka MT, et al
    Microglia modulation through external vagus nerve stimulation in a murine model of Alzheimer's disease.
    J Neurochem. 2017 Dec 21. doi: 10.1111/jnc.14284.
    PubMed     Abstract available

  75. TAPIA-ROJAS C, Inestrosa NC
    Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    J Neurochem. 2017 Dec 14. doi: 10.1111/jnc.14278.
    PubMed     Abstract available

  76. BRACZYNSKI AK, Schulz JB, Bach JP
    Vaccination strategies in tauopathies and synucleinopathies.
    J Neurochem. 2017;143:467-488.
    PubMed     Abstract available

  77. KAWANO H, Oyabu K, Yamamoto H, Eto K, et al
    Astrocytes with previous chronic exposure to amyloid beta-peptide fragment 1-40 suppress excitatory synaptic transmission.
    J Neurochem. 2017;143:624-634.
    PubMed     Abstract available

  78. COLVIN BA, Rogers VA, Kulas JA, Ridgway EA, et al
    The conformational epitope for a new Abeta42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    J Neurochem. 2017;143:736-749.
    PubMed     Abstract available

    November 2017
  79. MOLNAR E
    New tool to tackle Alzheimer's disease: amyloid-beta protofibril-selective antibody AbSL: An Editorial Highlight for 'The conformational epitope for a new Abeta42 protofibril-selective antibody partially overlaps with the peptide N-terminal region' on
    J Neurochem. 2017 Nov 23. doi: 10.1111/jnc.14240.
    PubMed     Abstract available

  80. KUSAKARI S, Nawa M, Sudo K, Matsuoka M, et al
    Calmodulin-like skin protein protects against spatial learning impairment in a mouse model of Alzheimer disease.
    J Neurochem. 2017 Nov 21. doi: 10.1111/jnc.14258.
    PubMed     Abstract available

  81. NDAY CM, Eleftheriadou D, Jackson G
    Shared Pathological Pathways of Alzheimer's disease with Specific Comorbidities: Current Perspectives and Interventions.
    J Neurochem. 2017 Nov 21. doi: 10.1111/jnc.14256.
    PubMed     Abstract available

  82. CHANEY A, Bauer M, Bochicchio D, Smigova A, et al
    Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe xPS1Deltae9 transgenic mouse model of Alzheimer's disease.
    J Neurochem. 2017 Nov 10. doi: 10.1111/jnc.14251.
    PubMed     Abstract available

    October 2017
  83. BEHL C, Ziegler C
    Beyond Amyloid - Widening the View on Alzheimer's Disease.
    J Neurochem. 2017 Oct 20. doi: 10.1111/jnc.14137.
    PubMed     Abstract available

    A mobile APP for sharing contacts on your cell: An Editorial Highlight for 'The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system' on page 11.
    J Neurochem. 2017;143:9-10.
    PubMed     Abstract available

  85. SOSA LJ, Caceres A, Dupraz S, Oksdath M, et al
    The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system.
    J Neurochem. 2017;143:11-29.
    PubMed     Abstract available

    August 2017
  86. ROUBROEKS JAY, Smith RG, van den Hove DLA, Lunnon K, et al
    Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
    J Neurochem. 2017 Aug 14. doi: 10.1111/jnc.14148.
    PubMed     Abstract available

    July 2017
  87. LAI AY, McLaurin J
    Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.
    J Neurochem. 2017 Jul 19. doi: 10.1111/jnc.14130.
    PubMed     Abstract available

  88. CHENG S, Wani WY, Hottman DA, Jeong A, et al
    Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.
    J Neurochem. 2017;142:297-304.
    PubMed     Abstract available

  89. NIGAM SM, Xu S, Kritikou JS, Marosi K, et al
    Exercise and BDNF reduce Abeta production by enhancing alpha-secretase processing of APP.
    J Neurochem. 2017;142:286-296.
    PubMed     Abstract available

    May 2017
  90. TSE KH, Herrup K
    Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.
    J Neurochem. 2017 May 26. doi: 10.1111/jnc.14079.
    PubMed     Abstract available

  91. COULSON EJ, Bartlett PF
    An exercise path to preventing Alzheimer's disease: An Editorial Highlight on 'Exercise and BDNF reduce Ab production by enhancing alpha-secretase processing of APP'.
    J Neurochem. 2017 May 18. doi: 10.1111/jnc.14038.
    PubMed     Abstract available

  92. SILMAN I, Sussman JL
    Recent developments in structural studies on acetylcholinesterase.
    J Neurochem. 2017 May 15. doi: 10.1111/jnc.13992.
    PubMed     Abstract available

  93. RODRIGUEZ L, Mohamed NV, Desjardins A, Lippe R, et al
    Rab7A regulates tau secretion.
    J Neurochem. 2017;141:592-605.
    PubMed     Abstract available

    April 2017
  94. ARENDT T, Stieler J, Ueberham U
    Is sporadic Alzheimer's disease a developmental disorder?
    J Neurochem. 2017 Apr 11. doi: 10.1111/jnc.14036.
    PubMed     Abstract available

    March 2017
  95. PUCHOWICZ MA, Seyfried TN
    Novel ketone body therapy for managing Alzheimer's disease: An Editorial Highlight for Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's diseas
    J Neurochem. 2017 Mar 15. doi: 10.1111/jnc.13979.
    PubMed     Abstract available

  96. BRANDT R, Bakota L
    Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.
    J Neurochem. 2017 Mar 7. doi: 10.1111/jnc.14011.
    PubMed     Abstract available

    February 2017
  97. GRALLE M
    The neuronal insulin receptor in its environment.
    J Neurochem. 2017;140:359-367.
    PubMed     Abstract available

    January 2017
  98. PAWLOSKY RJ, Kemper MF, Kashiwaya Y, King MT, et al
    Effects of a dietary ketone ester on hippocampal glycolytic and TCA cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
    J Neurochem. 2017 Jan 18. doi: 10.1111/jnc.13958.
    PubMed     Abstract available

  99. YAMIN G, Teplow DB
    Pittsburgh Compound-B (PiB) binds amyloid beta-protein protofibrils.
    J Neurochem. 2017;140:210-215.
    PubMed     Abstract available

    December 2016
  100. WHYTE LS, Lau AA, Hemsley KM, Hopwood JJ, et al
    Endo-lysosomal and autophagic dysfunction: A driving factor in Alzheimer's disease?
    J Neurochem. 2016 Dec 27. doi: 10.1111/jnc.13935.
    PubMed     Abstract available

  101. SALMINEN A, Kauppinen A, Kaarniranta K
    Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.
    J Neurochem. 2016 Dec 17. doi: 10.1111/jnc.13932.
    PubMed     Abstract available

  102. YI B, Sahn JJ, Ardestani PM, Evans AK, et al
    Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuro-inflammation in experimental models of Alzheimer's disease.
    J Neurochem. 2016 Dec 7. doi: 10.1111/jnc.13917.
    PubMed     Abstract available

    November 2016
  103. ELLISON EM, Abner EL, Lovell MA
    Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.
    J Neurochem. 2016 Nov 27. doi: 10.1111/jnc.13912.
    PubMed     Abstract available

    September 2016
  104. IMAMURA O, Arai M, Dateki M, Takishima K, et al
    Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis.
    J Neurochem. 2016 Sep 24. doi: 10.1111/jnc.13856.
    PubMed     Abstract available

  105. MURAMATSU I, Yoshiki H, Uwada J, Masuoka T, et al
    Pharmacological evidence of specific acetylcholine transport in rat cerebral cortex and other brain regions.
    J Neurochem. 2016 Sep 14. doi: 10.1111/jnc.13843.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.